Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
about
Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.Feedback as a strategy to change behaviour: the devil is in the details.Explicit review of risperidone long-acting injection prescribing practice.Worldwide Differences in Regulations of Clozapine Use.Clozapine: a distinct, poorly understood and under-used molecule.Pathway to clozapine use: a comparison between a patient cohort from New Zealand and a cohort from the United Kingdom.
P2860
Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
@en
Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
@nl
type
label
Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
@en
Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
@nl
prefLabel
Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
@en
Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
@nl
P2093
P2860
P1476
Impact of audit and feedback on antipsychotic prescribing in schizophrenia.
@en
P2093
Elizabeth Robinson
Peter Joyce
Verity Humberstone
P2860
P304
P356
10.1111/J.1365-2753.2008.01032.X
P577
2009-04-02T00:00:00Z